Award
National Cancer Institute 11447033
Multi-directed prime-pull cancer immunotherapy using super-adjuvant nanoparticles
Recipient
University of Massachusetts Amherst
Award Amount
$416,468.00
Ceiling
$416,468.00
Awarded
June 29, 2026
Identifier
11447033
Award for cancer immunotherapy research using super-adjuvant nanoparticles targeting metastatic melanoma, funded by NIH and awarded to University of Massachusetts Amherst.
Description
This project involves research on a dual-adjuvant, dual-delivery nanoparticle approach for cancer immunotherapy, specifically targeting metastatic melanoma. The project is funded by the NIH and involves the University of Massachusetts Amherst and the National Cancer Institute.